BioMaxima SA
WSE:BMX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioMaxima SA
WSE:BMX
|
PL |
Intrinsic Value
The intrinsic value of BioMaxima SA (BMX) under the Base Case is 13.46 PLN per share. Compared with the current market price of 9.85 PLN, the stock appears Undervalued by 27% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What BioMaxima Does
BioMaxima SA makes diagnostic products used by laboratories, hospitals, and medical clinics to test patient samples. Its core business is in vitro diagnostics, which means tests done on blood, urine, and other samples outside the body to help detect disease, monitor health, and support medical decisions. The company sells reagent kits, diagnostic panels, and related laboratory materials that doctors and labs use every day.
- Headquarters
- Poland PL
- IPO date
- Jun 8, 2010
Earnings Waterfall
BioMaxima SA
The intrinsic value for BioMaxima SA (BMX) under the Base Case is 13.46 PLN.
Compared with the current market price of 9.85 PLN, the stock appears Undervalued by 27% .